View Older Stories View More Recent Stories
-
TrueBlue Reports Second Quarter 2025 Results
-
BayFirst discontinues SBA loan program, cuts 51 jobs
-
Dorman Products, Inc. Reports Second Quarter 2025 Results and Raises Full Year 2025 Guidance
-
Wayfair Announces Second Quarter 2025 Results, Reports Highest Revenue Growth and Profitability Since 2021
-
Berkshire takes $3.8 billion Kraft Heinz write-down, operating profit falls
-
Trump administration blocks funding for CDC health programs, WSJ reports
-
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
-
Republican US Representative Brian Steil booed over Trump tariffs
-
Data credibility fears fueled after Trump orders firing of labor official
-
South Africa's finance minister and central bank governor at odds over inflation target
-
Daimler Truck warns of tougher H2 after outlook cut, shares lower
-
China's solar giants quietly shed a third of their workforces last year
-
US labor market cracks widen as job growth hits stall speed
-
AES Reports Second Quarter 2025 Results; On Track to Deliver on 2025 Guidance and Long-Term Targets
-
Ballard Power Systems plans workforce cuts to reach cash flow positive by 2027
-
Fortune Brands Delivers Solid Execution and Outperforms End Market; Provides Updated Full Year 2025 Guidance
-
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
-
OPM Announces Its 2025 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position
-
India's garment and jewellery sectors fear for US orders after tariff shock
-
PPL Corporation reports second-quarter 2025 earnings
-
Xerox Releases Second-Quarter Results
-
Unilever beats sales forecasts as ice cream business shines
-
Invisalign maker Align Technology cuts annual revenue forecast on weak demand
-
Albemarle posts surprise second-quarter profit on lithium demand; shares surge
-
Align Technology Announces Second Quarter 2025 Financial Results
-
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
-
PTC ANNOUNCES THIRD FISCAL QUARTER 2025 RESULTS
-
US Senate confirms Trump nominee Susan Monarez as CDC director
-
RESCON discusses challenges facing residential construction industry with federal housing minister
-
ETQ Continues its Growth Momentum in Second Quarter of 2025, Scales its Leadership Position in Quality Management
-
Washington, D.C. Housing Supply Rose 23% in June—One of the Biggest Jumps on Record
-
Porsche trims outlook in 'storm' of US tariff woes and China slump
-
Sherritt Reports Second Quarter 2025 Results and Updated Guidance; Moa JV Expansion Phase Two Ramp Up Commencing; Further Cost Reductions
-
Inventiva Reports Preliminary 2025 First-Half Financial Information¹
-
Brazil asks US to spare food products, Embraer planes from 50% tariff, source says
-
GTT : First half 2025 results - Strong growth in revenue and EBITDA
-
South Africa says US pushback against domestic race policies complicating trade deal
-
Union Pacific to reshape US freight rail with $85 billion deal for Norfolk
-
Fulcrum Therapeutics reports Q2 results, pociredir trial data
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
-
Fulcrum reports positive Phase 1b trial results for sickle cell drug
-
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
-
UPS Releases 2Q 2025 Earnings
-
H1 2025 Results: Increase in Operating Margin & Net Cash Flow, Transformation Underway, Guidance Confirmed
-
China's industrial profits fall further in June
-
Will Nissan remain a fallen angel? Bernstein answers
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $10 at Canaccord Genuity
-
FLAGSTAR FINANCIAL, INC. REPORTS SECOND QUARTER 2025 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.19 PER DILUTED SHARE AND ADJUSTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.14 PER DILU
-
Sterling at four month low against euro as UK and euro zone rates diverge
-
US dollar rises, but on track for weekly drop ahead of Fed, BOJ

